Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer

被引：0
|
作者：
Tsukasa Hasegawa
Noriko Yanagitani
Fumiyoshi Ohyanagi
Keita Kudo
Atsushi Horiike
Yuichi Tambo
Shingo Nishikawa
Ryo Ariyasu
Ken Uchibori
Satoru Kitazono
Makoto Nishio
机构：
[1] The Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Thoracic Medical Oncology
[2] Jichi Medical University Saitama Medical Center,Division of Pulmonary Medicine, Clinical Department of Internal Medicine
[3] National Hospital Organization Osaka Minami Medical Center,Department of Medical Oncology and Respiratory Medicine
[4] Showa University School of Medicine,Division of Medical Oncology, Department of Medicine
[5] Kanazawa University Hospital,Department of Respiratory Medicine
来源：
International Journal of Clinical Oncology | 2021年 / 26卷
关键词：
Non-small-cell lung cancer; Non-squamous; Bevacizumab; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：507 / 514
页数：7
相关论文
共 50 条
  • [1] Phase II study of the combination of S-1 with bevacizumab for patients with previously treated advanced non-squamous non-small-cell lung cancer
    Hasegawa, Tsukasa
    Yanagitani, Noriko
    Ohyanagi, Fumiyoshi
    Kudo, Keita
    Horiike, Atsushi
    Tambo, Yuichi
    Nishikawa, Shingo
    Ariyasu, Ryo
    Uchibori, Ken
    Kitazono, Satoru
    Nishio, Makoto
    [J]. INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2021, 26 (03) : 507 - 514
  • [2] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
    Yu Nishijima-Futami
    Seigo Minami
    Shinji Futami
    Taro Koba
    Masayoshi Higashiguchi
    Motohiro Tamiya
    Hidekazu Suzuki
    Tomonori Hirashima
    Kiyoshi Komuta
    Takashi Kijima
    [J]. Cancer Chemotherapy and Pharmacology, 2017, 79 : 1215 - 1220
  • [3] Phase II Study of S-1 plus Bevacizumab Combination Therapy for Patients Previously Treated for Non-Squamous Non-Small Cell Lung Cancer
    Masuhiro, K.
    Nishijima-Futami, Y.
    Minami, S.
    Futami, S.
    Koba, T.
    Higashiguchi, M.
    Tamiya, M.
    Suzuki, H.
    Hirashima, T.
    Komuta, K.
    Kijima, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1968 - S1968
  • [4] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer
    Nishijima-Futami, Yu
    Minami, Seigo
    Futami, Shinji
    Koba, Taro
    Higashiguchi, Masayoshi
    Tamiya, Motohiro
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Komuta, Kiyoshi
    Kijima, Takashi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1215 - 1220
  • [5] Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer
    M. Wada
    M. Yamamoto
    S. Ryuge
    Y. Nagashima
    N. Hayashi
    S. Maki
    S. Otani
    K. Katono
    A. Takakura
    T. Yanaihara
    S. Igawa
    M. Yokoba
    H. Mitsufuji
    M. Kubota
    M. Katagiri
    N. Masuda
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 1005 - 1011
  • [6] Phase II study of S-1 monotherapy in patients with previously treated, advanced non-small-cell lung cancer
    Wada, M.
    Yamamoto, M.
    Ryuge, S.
    Nagashima, Y.
    Hayashi, N.
    Maki, S.
    Otani, S.
    Katono, K.
    Takakura, A.
    Yanaihara, T.
    Igawa, S.
    Yokoba, M.
    Mitsufuji, H.
    Kubota, M.
    Katagiri, M.
    Masuda, N.
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 1005 - 1011
  • [7] A randomized phase II study of bevacizumab in combination with docetaxel or S-1 in patients with non-squamous non-small-cell lung cancer previously treated with platinum based chemotherapy (HANSHIN Oncology Group 0110)
    Nishino, Kazumi
    Imamura, Fumio
    Kumagai, Toru
    Katakami, Nobuyuki
    Hata, Akito
    Okuda, Chiyuki
    Urata, Yoshiko
    Hattori, Yosihihiro
    Tachihara, Motoko
    Yokota, Souichirou
    Nishimura, Takashi
    Kaneda, Toshihiko
    Satouchi, Miyako
    Morita, Satoshi
    Negoro, Shunichi
    [J]. LUNG CANCER, 2015, 89 (02) : 146 - 153
  • [8] Bevacizumab with Single-agent Chemotherapy in Previously Treated Non-squamous Non-small-cell Lung Cancer: Phase II Study
    Yamaguchi, Kakuhiro
    Masuda, Takeshi
    Fujitaka, Kazunori
    Miwata, Kei
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Hamai, Kosuke
    Miyamoto, Shintaro
    Nakashima, Taku
    Okamoto, Yohei
    Iwamoto, Hiroshi
    Ishikawa, Nobuhisa
    Miyata, Yoshihiro
    Okada, Morihito
    Hamada, Hironobu
    Hattori, Noboru
    [J]. IN VIVO, 2018, 32 (05): : 1155 - 1160
  • [9] Phase II Study of Docetaxel-plus-Bevacizumab Combination Therapy in Patients Previously Treated for Advanced Non-squamous Non-small Cell Lung Cancer
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Kawano, Yuko
    Sakatani, Toshio
    Tanimoto, Azusa
    Nishizawa, Hironari
    Horiike, Atsushi
    Hagiwara, Sachiko
    Horai, Takeshi
    Nishio, Makoto
    [J]. ANTICANCER RESEARCH, 2014, 34 (09) : 5153 - 5158
  • [10] Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer
    Kaira, Kyoichi
    Tomizawa, Yoshio
    Yoshino, Reiko
    Miura, Yosuke
    Yoshii, Akihiro
    Iwasaki, Yasuki
    Koga, Yasuhiko
    Ono, Akihiro
    Hisada, Takeshi
    Minato, Koichi
    Sato, Koji
    Kazama, Toshifumi
    Ishihara, Shinichi
    Kohyama, Kenya
    Fueki, Naoto
    Saito, Ryusei
    Sunaga, Noriaki
    [J]. LUNG CANCER, 2013, 82 (01) : 103 - 108
12345